Daiwa Securities Group Inc. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 79 filers reported holding SERES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1
-50.0%
5010.0%0.00%
Q2 2023$2
-33.3%
5010.0%0.00%
Q1 2023$30.0%5010.0%0.00%
Q4 2022$3
-99.8%
501
+59.6%
0.00%
Q3 2022$2,000
+100.0%
3140.0%0.00%
Q2 2022$1,000
-50.0%
3140.0%0.00%
Q1 2022$2,000
-33.3%
3140.0%0.00%
Q4 2021$3,000
+50.0%
3140.0%0.00%
Q3 2021$2,000
-50.0%
314
+82.6%
0.00%
Q2 2021$4,0000.0%1720.0%0.00%
Q1 2021$4,0000.0%1720.0%0.00%
Q4 2020$4,000
-69.2%
172
-61.3%
0.00%
Q3 2020$13,000
+550.0%
4450.0%0.00%
Q2 2020$2,0000.0%4450.0%0.00%
Q1 2020$2,0000.0%4450.0%0.00%
Q4 2019$2,0000.0%4450.0%0.00%
Q3 2019$2,000
+100.0%
445
+98.7%
0.00%
Q2 2019$1,000
-50.0%
2240.0%0.00%
Q1 2019$2,000
+100.0%
2240.0%0.00%
Q4 2018$1,000
-50.0%
2240.0%0.00%
Q3 2018$2,0000.0%2240.0%0.00%
Q2 2018$2,0000.0%2240.0%0.00%
Q1 2018$2,0002240.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 14,378,802$342,935,0004.38%
SILVERARC CAPITAL MANAGEMENT, LLC 122,700$2,926,0001.30%
COMMODORE CAPITAL LP 145,453$3,469,0001.21%
Asymmetry Capital Management, L.P. 63,259$1,509,0001.04%
Opaleye Management Inc. 250,000$5,963,0000.99%
Ikarian Capital, LLC 500,000$11,924,0000.96%
HighVista Strategies LLC 44,750$1,068,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 63,915$1,524,0000.68%
Altium Capital Management LP 104,626$2,495,0000.58%
Integral Health Asset Management, LLC 75,000$1,789,0000.49%
View complete list of SERES THERAPEUTICS INC shareholders